Among the world’s most iconic digital billboards, TibaRay is highlighted as a breakthrough company
For years, our team has been dedicated to creating a future where cancer care is quicker, more accurate, and more widely available to patients everywhere.”— Thinh Tran, CEO of TibaRaySILICON VALLEY, CA, UNITED STATES, July 29, 2026 /EINPresswire.com/ — A Silicon Valley med-tech firm, TibaRay, was spotlighted on the Nasdaq Tower in New York City’s Times Square today. This opportunity came through its selection by Lehigh University’s Startup Academy and marks the company’s progress toward bringing next‑generation precision radiation therapy to market. The honor follows a string of recent achievements for TibaRay, including continued advancement of its Galactica™ platform as the Stanford‑born enterprise works to deliver innovative cancer treatment options to patients.
This feature places TibaRay among the innovative companies shown on one of the most recognizable digital billboards in the world, highlighting the organization’s headway and rising profile within the medical‑technology sector. The chance to appear on the billboard was made possible through TibaRay’s collaboration with Lehigh University’s Startup Academy, which chose the company for its novel approach to fighting cancer and its dedication to entrepreneurship.
Rooted in Stanford University research, TibaRay is building the Galactica upright‑linac radiation therapy platform. The system is designed to boost patient comfort while delivering highly targeted cancer therapy in a more compact and efficient setup. The platform also sets the stage for future FLASH treatment—an emerging radiation approach that delivers a dose in under a second and has shown promise in destroying tumors while sparing healthy tissue from damage.
“Every milestone moves us closer to making the next generation of radiation therapy available to patients,” stated Thinh Tran, CEO of TibaRay. “Our team has spent years working toward a future where cancer treatment is faster, more precise and more accessible for patients around the world. Being featured on the Nasdaq Tower is an exciting moment that reinforces our commitment to bringing this innovative technology to the patients who need it most.”
Radiation therapy is used in the care of nearly half of all cancer patients, highlighting the demand for ongoing innovation that improves precision, efficiency, and the patient experience. As TibaRay continues to advance toward commercialization, the company stays focused on speeding up the development of next‑generation radiation‑therapy technologies that could improve outcomes, broaden access to advanced cancer care, and shape the future of oncology.
Those interested in supporting TibaRay’s continued growth can learn more about its current investment opportunity at Wefunder.com/TibaRay. For additional information, please visit TibaRay.com.
###
About TibaRay
TibaRay is a medical‑technology company advancing innovative linear accelerator technology for radiotherapy and other commercial uses. The company’s next‑generation accelerator platform is built to help physicians deliver radiotherapy with greater precision, speed, and efficiency, while also enabling broader applications of compact, high‑performance linear accelerators beyond cancer treatment.
Based on technology developed at Stanford University, TibaRay combines expertise in physics, engineering, and medicine to push forward the future of radiation technology. Headquartered in Fremont, California, TibaRay is driven by its mission of Curing Cancer in a FLASH™. To learn more, visit TibaRay.com.
###
Karla Nafarrate
InnoVision Marketing Group
email us here
